Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 3/2015

01-06-2015 | Original Article

Influence of the glycation gap on the diagnosis of type 2 diabetes

Authors: Santiago Rodriguez-Segade, Javier Rodriguez, José M. García-López, Felipe F. Casanueva, Ian C. Coleman, Carmen Alonso de la Peña, Félix Camiña

Published in: Acta Diabetologica | Issue 3/2015

Login to get access
Metadata
Title
Influence of the glycation gap on the diagnosis of type 2 diabetes
Authors
Santiago Rodriguez-Segade
Javier Rodriguez
José M. García-López
Felipe F. Casanueva
Ian C. Coleman
Carmen Alonso de la Peña
Félix Camiña
Publication date
01-06-2015
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2015
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-014-0666-z

Other articles of this Issue 3/2015

Acta Diabetologica 3/2015 Go to the issue

Original Article

Exome sequencing identifies novel ApoB loss-of-function mutations causing hypobetalipoproteinemia in type 1 diabetes

Original Article

Serum aryl hydrocarbon receptor ligand activity is associated with insulin resistance and resulting type 2 diabetes

Original Article

Low-educated women have an increased risk of gestational diabetes mellitus: the Generation R Study

Original Article

Nationwide reduction in the frequency of severe hypoglycemia by half

Review Article

Insulin and GH–IGF-I axis: endocrine pacer or endocrine disruptor?

Letter to the Editor

Positive conversion of GAD autoantibody in patients with presumed type 2 diabetes

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits